Frequency of CYP2C9 polymorphisms in Polynesian people and potential relevance to management of gout with benzbromarone. [electronic resource]
- Joint bone spine Mar 2014
- 160-3 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1778-7254
10.1016/j.jbspin.2013.07.006 doi
Aryl Hydrocarbon Hydroxylases--genetics Benzbromarone--therapeutic use Cytochrome P-450 CYP2C9 Gout--drug therapy Gout Suppressants--therapeutic use Humans New Zealand--ethnology Polymorphism, Single Nucleotide Polynesia--ethnology White People